10:14 EDT Insmed (INSM) trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed’s Earnings Call Highlights Strong Portfolio and Growth
- Insmed price target raised to $120 from $108 at RBC Capital
- Insmed price target raised to $133 from $124 at UBS
- Insmed Positioned for Growth: Buy Rating Backed by Brensocatib Launch and Strong Pipeline
- Insmed Reports Strong Growth and Strategic Advances